Psychiatry and Neurology, Neurology · Altamonte Springs, FL
NPI
1770789000
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
405 W Central Pkwy Ste 1000
Altamonte Springs, FL, 32714
Phone (407) 790-4990
Groups this clinician bills Medicare through
Medicare paid, 2024
$844K
28,016 services
Medicare patients, 2024
631
Average age 74
Drug cost, 2024
$5.8M
15,097 prescriptions
Company payments, 2025
$8,090
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alicia V Cabrera was code J0585 (injection, onabotulinumtoxina, 1 unit), 12,629 times for 25 patients. In total Alicia V Cabrera billed 28,016 services in 45 codes, and Medicare paid $844K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 12,629 | 25 | $4.97 | $63K |
| 99214 Office E&M - Established | Office | 1,955 | 547 | $86.86 | $170K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 946 | 410 | $12.54 | $12K |
| 95886 Electrical Nerve Conductivity | Office | 320 | 203 | $142.12 | $45K |
| 95819 Neurologic | Office | 199 | 198 | $329.59 | $66K |
| 99215 Office E&M - Established | Office | 177 | 141 | $125.07 | $22K |
| 95910 Electrical Nerve Conductivity | Office | 155 | 153 | $128.28 | $20K |
| 95912 Electrical Nerve Conductivity | Office | 141 | 141 | $184.54 | $26K |
| 99204 Office E&M - New | Office | 129 | 129 | $118.55 | $15K |
| 99212 Office E&M - Established | Office | 82 | 32 | $40.53 | $3,324 |
| 95921 Electrical Nerve Conductivity | Office | 67 | 67 | $66.34 | $4,445 |
| 95700 Neurologic | Office | 67 | 57 | $203.15 | $14K |
| 95923 Electrical Nerve Conductivity | Office | 67 | 67 | $89.63 | $6,005 |
| 93922 Duplex Scan - Extremity Arteries | Office | 66 | 66 | $61.26 | $4,043 |
| 95718 Neurologic | Office | 64 | 57 | $105.48 | $6,750 |
By year: 2022 $490K for 10,467 services; 2023 $565K for 13,845 services; 2024 $844K for 28,016 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alicia V Cabrera prescribed most often to Medicare patients was Gabapentin, with 1,799 prescriptions and refills. In total Alicia V Cabrera wrote 15,097 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,799 | 3,537 | 575 | $32K |
| Donepezil Hcl Generic | 1,255 | 2,801 | 454 | $13K |
| Memantine Hcl Generic | 1,054 | 2,263 | 329 | $33K |
| Tizanidine Hcl Generic | 617 | 1,213 | 237 | $5,346 |
| Sertraline Hcl Generic | 505 | 1,140 | 172 | $3,441 |
| Nortriptyline Hcl Generic | 499 | 924 | 174 | $11K |
| Baclofen Generic | 492 | 978 | 170 | $7,138 |
| Levetiracetam Generic | 445 | 938 | 117 | $15K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 422 | 838 | 111 | $8,811 |
| Duloxetine Hcl Generic | 383 | 786 | 130 | $13K |
| Topiramate Generic | 341 | 712 | 104 | $3,434 |
| Rivastigmine Rivastigmine Tartrate | 269 | 562 | 86 | $17K |
| Lamotrigine Generic | 256 | 514 | 53 | $3,703 |
| Meloxicam Generic | 246 | 465 | 94 | $922 |
| Cyclobenzaprine Hcl Generic | 241 | 448 | 88 | $3,206 |
Brand drugs: - claims; generic drugs: 13,541 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alicia V Cabrera $8,090 ($7,995 in general payments such as food, travel and fees and $95.29 for research) from 38 companies. The largest payer was Genzyme Corporation with $2,222.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 5 | $2,222 |
| Neurocrine BioSciences, Inc. NBIX | 52 | $1,123 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $641 |
| Abbvie Inc. ABBV | 31 | $537 |
| TG Therapeutics, Inc. TGTX | 5 | $458 |
| Biogen, Inc. BIIB | 12 | $392 |
| EMD Serono, Inc. MRK.DE | 9 | $380 |
| Pfizer Inc. PFE | 21 | $372 |
| ACADIA Pharmaceuticals Inc ACAD | 19 | $319 |
| Janssen Biotech, Inc. JNJ | 4 | $270 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.